In a controlled experiment, SERPINB2 was found to be increased in eosinophilic chronic rhinosinusitis with nasal polyps (CRSwNP) nasal polyp epithelial cells and to promote T2 inflammation through STAT6 signaling, which could be considered a novel therapeutic target for CRSwNP. Here, SERPINB2 is linked to nasal cavity polyp.